A vascularized crypt-patterned colon model for high-throughput drug screening and disease modelling.

Area of Science:

• Biomedical Engineering
• Tissue Engineering
• Gastroenterology

Background:

• The colon is crucial for drug screening and disease modeling.
• Current in vitro colon models lack integrated crypt structures and vasculature.
• Vascular-epithelial crosstalk is vital in colon disease progression.

Purpose of the Study:

• To develop an advanced in vitro colon model with vascularized crypts.
• To recapitulate colon-specific physiological features and cytokine gradients.
• To enhance colon disease modeling and pharmaceutical compound screening.

Main Methods:

• Utilized the IFlowPlate384 platform to imprint crypt topography.
• Seeded colon cells onto patterned scaffolds to form epithelial barriers.
• Incorporated perfusable microvasculature and simulated inflammatory bowel disease (IBD) conditions using cytokines (TNFα and IFNγ).

Main Results:

• Colon cells formed differentiated epithelial barriers with tight brush borders within crypt niches.
• Demonstrated dose-dependent toxicity and recovery of capecitabine in the engineered colon model.
• Observed in vivo-like cytokine gradients and reversals under inflammatory conditions in vascularized crypt tissues.

Conclusions:

• The developed model integrates crypt topography with perfusable microvasculature.
• This advanced model effectively emulates colon physiology and disease states.
• Shows significant potential for pharmaceutical screening and in vitro colon disease modeling.